an anti-TNF compound (trade name Remicade) consisting of an antibody directed against TNF; it is given intravenously at one-month to three-month intervals; used in treatment of regional enteritis and rheumatoid arthritis
English language
Toggle Transcript
infliximab::noun | Spocien Dictionary
| Type | Words |
|---|---|
| Synonyms | remicade |
| Type of | anti-tnf compound |
infliximab::noun | Spocien Dictionary
a monoclonal antibody (trade name Remicade) used to treat Crohn's disease and rheumatoid arthritis; administered by infusion; use and dosage must be determined by a physician
| Type | Words |
|---|---|
| Synonyms | remicade |
| Type of | monoclonal, monoclonal antibody |
Examples of infliximab
infliximab
Over 40% of patients treated with adalimumab or infliximab develop ADA.
From the nature.com
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.
From the nature.com
Infliximab for induction and maintenance therapy for ulcerative colitis.
From the nature.com
Like infliximab, adalimumab is a human monoclonal antibody that blocks tumor necrosis factor.
From the sciencedaily.com
Patients on infliximab were most likely to drop out of a trial because of these side effects.
From the sciencedaily.com
Clinical and biological consequences of immunization to infliximab in pediatric Crohn's disease.
From the nature.com
In the late 1990's, entanercept, infliximab, and other biologic medication came on the market.
From the sciencedaily.com
Infliximab blocks the action of TNF alpha by preventing it from binding to its receptor in the cell.
From the sciencedaily.com
Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis.
From the nature.com
- A monoclonal antibody (trade name Remicade) used to treat Crohn's disease and rheumatoid arthritis; administered by infusion; use and dosage must be determined by a physician
- An anti-TNF compound (trade name Remicade) consisting of an antibody directed against TNF; it is given intravenously at one-month to three-month intervals; used in treatment of regional enteritis and rheumatoid arthritis
- Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-u03B1) and is used to treat autoimmune diseases. Infliximab was approved by the U.S...
- A monoclonal antibody that blocks the action of a cytokine called tumor necrosis factor alfa. It is being studied in the treatment and prevention of weight loss and loss of appetite in patients with advanced cancer. It belongs to the family of drugs called monoclonal antibodies.
- A commercially available TNFa inhibitor.
- A type of TNF-alpha blocker prescription medication that can be used to treat psoriasis.
